Newsroom Blog
SAN DIEGO, July 22, 2022 — Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on the development of immunologic‑based therapies for the prevention and treatment of disease, today announced topline data for its Phase 1b CLEAR clinical study to evaluate the effect of intranasal REVTx-99b on …
Publish Date:Jul 22, 2022, 7:18 AM ET
New York, NY, July 22, 2022 — From July 9 to July 10, the 2022 Caixin Summer Summer was held. In the section “Exploring the Sustainable Development Driven by Market”, Li Haipeng, deputy general manager and chief investment officer (fixed income) of China Southern Asset Management, shared his opinions. Host: China Southern Asset Management is …
Publish Date:Jul 22, 2022, 7:15 AM ET
PASCAGOULA, Miss., July 22, 2022 — HII (NYSE:HII) announced today that its Ingalls Shipbuilding division has been awarded a cost-plus-incentive-fee contract for engineering and design from the U.S. Navy for the next-generation guided-missile destroyer (DDG(X)) program. “We are excited to continue on this path with our Navy and industry partners,” Ingalls Shipbuilding President Kari Wilkinson …
Continue reading “HII’s Ingalls Shipbuilding Awarded DDG(X) Design Engineering Contract”
Publish Date:Jul 22, 2022, 7:13 AM ET
Plant-Based Twists to Classic Summer Dishes
Publish Date:Jan 18, 2022, 6:29 PM ET
Health and Safety Priorities as the Weather Warms Up
Publish Date:Jan 18, 2022, 6:28 PM ET
